Korio, Inc.
PrivateLast Round
Series A
Sep 10, 2024
Est. Valuation
$17M
Total Funding Raised
$12.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Korio, Inc. operates in Healthcare & Life Sciences and is based in Doylestown, Pennsylvania. Its latest recorded funding round was a Series A round in September 2024.
Korio, Inc. is a healthtech company that provides a technology-first Randomization & Trial Supply Management (RTSM) platform for clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Korio, Inc. Comparables
Compare Korio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 4G Clinical | 87% | |
| Suvoda | 84% | |
| Medrio | 81% |
For institutional investors. Book with your work email.
Korio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 10, 2024 | ||||
| Seed | Oct 10, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Korio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIP Ventures | Series A |
| Boston Millennia Partners | Series A, Seed |
| Excelerate Health Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 90% MoM, reaching 3.6K.
- Jul 25, 2026
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
Korio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Korio, Inc.'s valuation, stock price, and market status.
Is Korio, Inc. a public or private company?
Korio, Inc. is a private company.
What is the current stock price of Korio, Inc.?
Korio, Inc. is a private company, so its shares have no public market price. Caplight tracks Korio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Korio, Inc. worth (valuation)?
Korio, Inc.'s valuation is estimated at $17.0M based on funding round data.
Can I buy Korio, Inc. stock?
Korio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Korio, Inc.'s last funding round?
Korio, Inc.'s most recent funding round was Series A on September 10, 2024.
Who are the main investors in Korio, Inc.?
Key investors in Korio, Inc. include BIP Ventures, Excelerate Health Ventures.
Will Korio, Inc. IPO soon?
No public IPO plans have been announced for Korio, Inc..
How can I track Korio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Korio, Inc.'s shares on secondary markets.